PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.

Abstract Cognitive deficits are common, long-term sequelae in children and adolescents with congenital heart disease (CHD) who have undergone surgical palliation. However, there is a lack of a validated brief cognitive screening tool appropriate for the outpatient setting for adolescents with CHD. One candidate instrument is the Montreal Cognitive Assessment (MoCA) questionnaire.
PMID
Related Publications

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease.

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.

Predictors of Memory Deficits in Adolescents and Young Adults with Congenital Heart Disease Compared to Healthy Controls.

A validation study of the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) in Chinese older adults in Hong Kong.

Authors

Mayor MeshTerms
Keywords
Journal Title nursing research
Publication Year Start




PMID- 28448372
OWN - NLM
STAT- In-Process
DA  - 20170427
LR  - 20170429
IS  - 1538-9847 (Electronic)
IS  - 0029-6562 (Linking)
VI  - 66
IP  - 3
DP  - 2017 May/Jun
TI  - Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young
      Adults With and Without Congenital Heart Disease.
PG  - 222-230
LID - 10.1097/NNR.0000000000000192 [doi]
AB  - BACKGROUND: Cognitive deficits are common, long-term sequelae in children and
      adolescents with congenital heart disease (CHD) who have undergone surgical
      palliation. However, there is a lack of a validated brief cognitive screening
      tool appropriate for the outpatient setting for adolescents with CHD. One
      candidate instrument is the Montreal Cognitive Assessment (MoCA) questionnaire.
      OBJECTIVE: The purpose of the research was to validate scores from the MoCA
      against the General Memory Index (GMI) of the Wide Range Assessment of Memory and
      Learning, 2nd Edition (WRAML2), a widely accepted measure of cognition/memory, in
      adolescents and young adults with CHD. METHODS: We administered the MoCA and the 
      WRAML2 to 156 adolescents and young adults ages 14-21 (80 youth with CHD and 76
      healthy controls who were gender and age matched). Spearman's rank order
      correlations were used to assess concurrent validity. To assess construct
      validity, the Mann-Whitney U test was used to compare differences in scores in
      youth with CHD and the healthy control group. Receiver operating characteristic
      curves were created and area under the curve, sensitivity, specificity, positive 
      predictive value, and negative predictive value were also calculated. RESULTS:
      The MoCA median scores in the CHD versus healthy controls were (23, range 15-29
      vs. 28, range 22-30; p < .001), respectively. With the screening cutoff scores at
      <26 points for the MoCA and 85 for GMI (<1 SD, M = 100, SD = 15), the CHD versus 
      healthy control groups showed sensitivity of .96 and specificity of .67 versus
      sensitivity of .75 and specificity of .90, respectively, in the detection of
      cognitive deficits. A cutoff score of 26 on the MoCA was optimal in the CHD
      group; a cutoff of 25 had similar properties except for a lower negative
      predictive value. The area under the receiver operating characteristic curve (95%
      CI) for the MoCA was 0.84 (95% CI [0.75, 0.93], p < .001) and 0.84 (95% CI [0.62,
      1.00], p = .02) for the CHD and controls, respectively. DISCUSSION: Scores on the
      MoCA were valid for screening to detect cognitive deficits in adolescents and
      young adults aged 14-21 with CHD when a cutoff score of 26 is used to
      differentiate youth with and without significant cognitive impairment. Future
      studies are needed in other adolescent disease groups with known cognitive
      deficits and healthy populations to explore the generalizability of validity of
      MoCA scores in adolescents and young adults.
FAU - Pike, Nancy A
AU  - Pike NA
AD  - Nancy A. Pike, PhD, RN, CPNP-AC, FAAN, is Associate Professor, School of Nursing,
      University of California, Los Angeles, and Pediatric Nurse Practitioner, Division
      of Cardiothoracic Surgery, Children's Hospital Los Angeles, California. Marie K. 
      Poulsen, PhD, is Chief Psychologist, Division of General Pediatrics, Children's
      Hospital, Los Angeles, California. Mary A. Woo, PhD, RN, FAAN, is Professor,
      School of Nursing, University of California, Los Angeles.
FAU - Poulsen, Marie K
AU  - Poulsen MK
FAU - Woo, Mary A
AU  - Woo MA
LA  - eng
GR  - R01 NR013930/NR/NINR NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nurs Res
JT  - Nursing research
JID - 0376404
PMC - PMC5408464
MID - NIHMS822105
EDAT- 2017/04/28 06:00
MHDA- 2017/04/28 06:00
CRDT- 2017/04/28 06:00
PMCR- 2018/05/01
AID - 10.1097/NNR.0000000000000192 [doi]
AID - 00006199-201705000-00003 [pii]
PST - ppublish
SO  - Nurs Res. 2017 May/Jun;66(3):222-230. doi: 10.1097/NNR.0000000000000192.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>